Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$148.36−1.16 (-0.78%)
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck DB Geographic Context by Quarter
DB Geographic Context — Consolidated U.S. Revenue ($M) ($M)
Merck DB Geographic Context: $9,367M in Q2 2026, up 6.0% from a year earlier.
Latest, Q2 2026
9,367
Period ended Jun 30, 2026
Change on a year earlier
+6.0%
8,836 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
30
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-07) ↗
Reported in Postgres DB segment_values (via lib/db.py).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DB Geographic Context — Consolidated U.S. Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 9,367 | +6.0% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 9,164 | +7.5% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 9,139 | +11.6% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 10,012 | +14.6% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 8,836 | +12.2% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 8,522 | +14.0% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 8,188 | +15.5% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 8,736 | +13.2% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 7,876 | +12.2% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 7,478 | +12.3% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 7,087 | +12.9% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 7,715 | +5.4% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 7,018 | +12.5% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Mar 31, 2023 | 6,659 | -9.3% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | 6,279 | +0.3% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 7,322 | +16.7% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 6,238 | +22.3% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 7,339 | +53.2% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 6,259 | +18.4% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 6,276 | +19.5% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 5,100 | +18.0% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 4,790 | -6.8% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 5,287 | +70.5% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 5,250 | -5.8% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 4,322 | -16.7% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2020 | Mar 31, 2020 | 5,137 | +13.0% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2019 | Dec 31, 2019 | 3,100 | -35.5% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 5,573 | +10.8% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 5,189 | +21.8% | Form 10-Q (filed 2020-08-05) ↗ |
| Q1 2019 | Mar 31, 2019 | 4,548 | +10.7% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2018 | Dec 31, 2018 | 4,803 | +11.0% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2018 | Sep 30, 2018 | 5,030 | +9.5% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 4,262 | -0.9% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2018 | Mar 31, 2018 | 4,107 | -0.7% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | 4,328 | – | Form 10-K (filed 2020-02-26) ↗ |
| Q3 2017 | Sep 30, 2017 | 4,594 | – | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2017 | Jun 30, 2017 | 4,300 | – | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2017 | Mar 31, 2017 | 4,138 | – | Form 10-Q (filed 2018-05-08) ↗ |
Breakdown
What makes up DB Geographic Context
- Consolidated EMEA Revenue ($M)3,920 · Q2 2026
- Consolidated China Revenue ($M)408 · Q2 2026
- Consolidated Japan Revenue ($M)577 · Q2 2026
- Consolidated Asia Pacific (ex-China & Japan) Revenue ($M)820 · Q2 2026
- Consolidated Latin America Revenue ($M)875 · Q2 2026
- Consolidated Other Countries Revenue ($M)640 · Q2 2026
- Consolidated Total International Revenue ($M)7,173 · Q2 2026
- Geographic Long-Lived Assets — United States ($M)15,291 · Q2 2026
- Geographic Long-Lived Assets — EMEA ($M)9,076 · Q2 2026
- Geographic Long-Lived Assets — China ($M)210 · Q2 2026
- Geographic Long-Lived Assets — Japan ($M)129 · Q2 2026
- Geographic Long-Lived Assets — Asia Pacific ($M)850 · Q2 2026
- Geographic Long-Lived Assets — Latin America ($M)131 · Q2 2026
- Geographic Long-Lived Assets — Other Countries ($M)50 · Q2 2026
Cite this data
StockData. (2026). Merck DB Geographic Context ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db-geo-us-rev
See every metric in the Merck KPI table. Data updated Oct 26, 2026.